Skip to content ↓

Stratton lecture will focus on privacy in information age

Three MIT professors and a former advisor to President Clinton on internet privacy will discuss "Privacy in the Age of Information" in the seventh annual Catherine N. Stratton Lecture on Critical Issues on Tuesday, Oct. 24 from 10am-noon in the Tang Center.

Admission is free and the public is invited.

The panelists are Institute Professor John M. Deutch, CIA director from 1995-96; Professor Ronald L. Rivest, founder of RSA Data Security; Professor Peter Szolovits, head of the Clinical Decision-Making Group at the Laboratory for Computer Science; and Washington attorney Christine Varney, a former Federal Trade Commissioner and White House advisor.

Among issues expected to be discussed are:
��������� Acceptable limitations on individual privacy.
��������� How to contain threats to privacy while allowing the market economy to function and the government to pursue criminals.
��������� Strategies to regulate businesses which seek individual transaction records in pursuit of market share.
��������� When wiretapping is appropriate.

A question and answer period will follow the discussion.

The Stratton Lectures are sponsored by the MIT Women's League. For additional information, contact Sis de Bordenave at the MIT Women's League at x3-3656 or wleague@ mit.edu.

A version of this article appeared in MIT Tech Talk on October 18, 2000.

Related Topics

More MIT News

Rich Nielsen, Volha Charnysh, Kevin Dorst, and Emily Richmond Pollock seated at a table, talking

Building a scholarly community

The SHASS Faculty Fellows Program, administered by the MIT Human Insight Collaborative, is fostering new research projects and creating space for supportive and interdisciplinary discussion.

Read full story

Globular blue and white orbs "examining" single-stranded RNA products and marking them with green checks or red x's

Why are some bacterial genes high in purines?

In certain species of bacteria, the answer lies in shielding RNA transcripts from a quality-control factor called Rho. Understanding the requirements for expressible sequences is critical for expression engineering of therapeutic agents.

Read full story